SANDU PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve 1.Approval of Standalone Unaudited Financial Results for Q ended 31st December 20242. any other matter with permission of chairman 1.Approval of Standalone Unaudited Financial Results for Q ended 31st December 20242. any other matter with permission of chairman